Global Fusion Biopsy Market

Global Fusion Biopsy Market Size, Trends & Analysis - Forecasts to 2026 By Component (Fully Integrated Biopsy System, Related Software and Post Sale Service), By Route of Biopsy (Transrectal Route and Transperineal Route), By End-User (Hospitals & Cancer Centers, Diagnostic & Imaging Labs, Outpatient Surgery Centers, and Academic & Research Institutes), By Region (Europe, North America, MEA, Asia Pacific, and CSA); Vendor Landscape, Company Market Share Analysis, End-User Landscape, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on April 25 2024 with the latest and most recent market numbers

Fusion Biopsy Market Insights

The fusion biopsy market is ought to grow from 2020 to 2026 with a 10.5% CAGR. Fusion biopsy system is simply the integrated use of MRI and ultrasound for biopsy guided screening and treatment of prostate cancer. Such merged technology helps many oncologists and urologists to accurately target the tumor region on the prostate organ and proceed further for biopsy.

Fusion biopsy technology is a classic replacement of the blind biopsy method which was earlier used to conduct screening. The blind biopsy did not involve the usage of any diagnostic imaging technology, which in turn caused collateral damage to normal cells or tissues of the prostate organ. The use of the fusion biopsy system for prostate cancer treatment and screening will change the dynamics of the medical device segment for oncology. The growing cancer cases will help the market grow faster than earlier. Other factors that will support the growth of this market are rising awareness and practice of the use of MRI, CT, PET scan, and ultrasound for oncology-related screening procedures, rising preference for avoiding a repeat biopsy during cancer treatment, increasing priority for a highly accurate and sensitive screening tool for prostate cancer, and increasing government support for the insurance coverage of fusion biopsy-based treatment.

Fusion Biopsy Market: By Type

Based on the components or parts of the fusion biopsy system, the market is segmented into a fully integrated fusion biopsy system, related software, and post-sale service. The fully integrated fusion biopsy system will be the fastest as well as the largest shareholder in the market owing to its rising demand for sensitive and accurate screening capabilities amongst prostate cancer patients and radiologists.

Fusion Biopsy Market: By Route of Biopsy

Based on the route or methodology of the biopsy the market can be segmented into the transrectal and transperineal route. The transrectal route being the oldest and gold standard technique for biopsy will rule the market with its higher share, however, the Transperineal route segment will witness a faster growth owing to its low-risk technique for biopsy.

Fusion Biopsy Market: By End-User

Based on end-user, the market can be segmented into hospitals & cancer centers, diagnostic & imaging labs, outpatient surgery centers, and academic & research institutes. The hospitals and cancer centers are the highest market share holders mainly due to the presence of high patient population, presence of advanced imaging systems, high financial capabilities, and the presence of skilled radiologists to use these machines.

Fusion Biopsy Market: By Region

The regional analysis study involves North America, Asia-Pacific, Europe, Middle East & Africa, & Central and South America. North America will be the top regional market owing to factors such as aggressive government support in the reimbursement department for diagnostic imaging procedures, rising awareness for advanced fusion technology for a one-time biopsy screening method, and rising patient population. Also, the Asia-Pacific region grows faster than in other regions. The increasing prostate cancer cases in the developing countries will help adopt the fusion biopsy systems in the market.

Fusion Biopsy Market Share and Competitor Analysis

Major companies offering such innovative fusion biopsy systems are KOELIS, Medical Targeting Technologies GmbH, Koninklijke Philips N.V., MedCom, innoMedicus Ltd., Siemens Healthineers, UltraMed Pty Ltd, ESAOTE SPA, Hitachi, Ltd., BioBot Surgical, Focal Healthcare, BK Medical Holding Company, Inc., and UC-Care Medical Systems Ltd.

Please note: This is not an exhaustive list of companies profiled in the report.

In January 2017, MIM Software Inc. launched MRI prostate fusion software to be fully integrated with BK Medical’s premium BK3000 system.

In February 2016, Focal Healthcare received FDA approval for its targeted prostate biopsy machine namely Fusion Bx.

Check the Press Release on Global Fusion Biopsy Market Report

Fusion Biopsy Market: By Component

Introduction
1. Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
Fully Integrated Biopsy System
1. Fully Integrated Biopsy System: Fusion Biopsy Market, 2018-2026 (USD Million)
Related Software
1. Related Software Post Sale Service: Fusion Biopsy Market, 2018-2026 (USD Million)
Post Sale Service
1. Post Sale Service: Fusion Biopsy Market, 2018-2026 (USD Million)

Fusion Biopsy Market: By Route of Biopsy

Introduction
1. Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
Transrectal Route
1. Transrectal Route: Fusion Biopsy Market, 2018-2026 (USD Million)
Transperineal Route
1. Transperineal Route: Fusion Biopsy Market, 2018-2026 (USD Million)

Fusion Biopsy Market: By End User

Introduction
1. Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
Hospitals & Cancer Centers
1. Hospitals & Cancer Centers: Fusion Biopsy Market, 2018-2026 (USD Million)
Diagnostic & Imaging Labs
1. Diagnostic & Imaging Labs: Fusion Biopsy Market, 2018-2026 (USD Million)
Outpatient Surgery Centers
1. Outpatient Surgery Centers: Fusion Biopsy Market, 2018-2026 (USD Million)
Academic & Research Institutes
1. Academic & Research Institutes: Fusion Biopsy Market, 2018-2026 (USD Million)

Fusion Biopsy Market: By Region

Introduction
1. Global Fusion Biopsy Market, Regional Analysis, 2018-2026 (USD Million)
North America
1. North America Fusion Biopsy Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Component
    1. North America Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
  2. By End User
    1. North America Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
  3. By Route of Biopsy
    1. North America Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
  4. By Country
    1. U.S.
      1. By Component
        
        U.S Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        U.S Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        U.S Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
    2. Canada.
      1. By Component
        
        Canada Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        Canada Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        Canada Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
    3. Mexico
      1. By Component
        
        Mexico Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        Mexico Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        Mexico Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
Europe
1. Europe Fusion Biopsy Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Component
    1. Europe Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
  2. By End User
    1. Europe Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
  3. By Route of Biopsy
    1. Europe Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
  4. By Country
    1. Germany
      1. By Component
        
        Germany Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        Germany Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        Germany Fusion Biopsy Market, By Vertical, 2018-2026 (USD Million)
    2. UK
      1. By Component
        
        UK Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        UK Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        UK Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
    3. France
      1. By Component
        
        France Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        France Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        France Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
    4. Italy
      1. By Component
        
        Italy Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        Italy Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        Italy Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
    5. Spain
      1. By Component
        
        Spain Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        Spain Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        Spain Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
    6. Rest Of Europe
      1. By Component
        
        Rest Of Europe Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        Rest Of Europe Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        Rest Of Europe Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
Asia Pacific
1. Asia Pacific Fusion Biopsy Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Component
    1. Asia Pacific Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
  2. By End User
    1. Asia Pacific Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
  3. By Route of Biopsy
    1. Asia Pacific Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
  4. By Country
    1. China
      1. By Component
        
        China Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        China Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        China Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
    2. Japan
      1. By Component
        
        Japan Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        Japan Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        Japan Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
    3. India
      1. By Component
        
        India Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        India Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        India Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
    4. South Korea
      1. By Component
        
        South Korea Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        South Korea Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        South Korea Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
    5. Rest Of APAC
      1. By Component
        
        Rest Of APAC Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        Rest Of APAC Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        Rest Of APAC Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
Central & South America
1. Central & South America Fusion Biopsy Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Component
    1. Central & South America Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
  2. By End User
    1. Central & South America Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
  3. By Route of Biopsy
    1. Central & South America Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
  4. By Country
    1. Brazil
      1. By Component
        
        Brazil Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        Brazil Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        Brazil Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
Middle East & Africa
1. Middle East & Africa Fusion Biopsy Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Component
    1. Middle East & Africa Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
  2. By End User
    1. Middle East & Africa Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
  3. By Route of Biopsy
    1. Middle East & Africa Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
  4. By Country
    1. Saudi Arabia
      1. By Component
        
        Saudi Arabia Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End User
        
        Saudi Arabia Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        Saudi Arabia Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)
    2. UAE
      1. By Component
        
        UAE Fusion Biopsy Market, By Component, 2018-2026 (USD Million)
      2. By End-User Industry
        
        UAE Fusion Biopsy Market, By End User, 2018-2026 (USD Million)
      3. By Route of Biopsy
        
        UAE Fusion Biopsy Market, By Route of Biopsy, 2018-2026 (USD Million)

The global Fusion Biopsy Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Fusion Biopsy Market.

Fusion Biopsy Market

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Fusion Biopsy Market

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.

Fusion Biopsy Market